CONVENE ADVISORS FOR A GROUP DISCUSSION

WITHIN

48 HOURS

100% ADVISOR

PARTICIPATION

DURING ADVISORY BOARD MEETINGS

ENHANCE

YOUR STRATEGY

IMPROVE YOUR STAKEHOLDER COMMUNICATIONS

WOULD YOU LIKE TO SCHEDULE A DEMO?

Why Within3?

18 of the top 20 pharmaceutical companies rely on us to gain better communication results.

We provide the safest, most advanced online discussion solution for connecting with external stakeholders.

Our product solutions produce an average of 33 pages of advisor output per session.

Case Study

MEDICAL AFFAIRS ADVISORY BOARD

Creating Effective Resources - Top 5 Pharma

Case Study

COMMERCIAL ADVISORY BOARD

Accelerating Education & Adoption – Top 5 Pharma

Case Study

R&D ADVISORY BOARD

Pursuing a New Indication – Top 25 Pharma

Featured Updates

February 11, 2016
The Institute of Medicine (IOM) defines patient-centered care as, “Providing care that is respectful of and responsive to individual patient preferences, needs and values, and ensuring that patient values guide all clinical decisions.” Practicing patient-centered care improves...
February 02, 2016
A couple weeks ago, we shared an infographic about the potential effect of the AMA’s support for a ban on direct-to-consumer (DTC) advertising. The topic has sparked controversy within the healthcare industry as we speculate the future of pharmaceutical marketing.  But, should it?
February 02, 2016
In the fall of 2015, the American Medical Association called for a ban on DTC (direct-to-consumer) advertising of prescription drugs and medical devices. The argument is based around the role that marketing costs allegedly play in the escalating drug prices. Here is a list of statistics in connecti...
February 02, 2016
We are happy to present the 13th meeting of the Future of Healthcare Professionals Collaboration Leadership Luncheon. The forum’s objective is to share experiences and lessons learned about how technology can enhance communication and dialogue between HCPs and the industry while breaking down...